Cyclotron and Radiopharmaceuticals Department (C&RD) is a state-of-the art facility for two primary activities: Radiopharmaceuticals manufacturing, and Radioisotope research. Radiopharmaceuticals manufacturing program is not only quite unique even for a major medical center, but also an essential component of KFSH&RC in providing the specialty services and quality patient care for the population of the Kingdom. On-demand and reliable availability of radiopharmaceuticals are essential components of viable nuclear medicine practice. C&RD manufactures a wide range of radiopharmaceuticals used in diagnostic medical imaging, as well as for radiotherapy. Products are manufactured according to the international and Saudi Food and Drug Authority (SFDA) standards of Good Manufacturing Practices (GMP), as well as in adherence to the ISO 9001 Quality Management System (QMS). The high-quality products are supplied to some 50 nuclear medicine centers throughout the Kingdom.

Radiopharmaceuticals manufactured at the C&RD facility are characterized by the relatively short to ultra-short half-life of the radioisotope contained within. Therefore, the optimum utilization of these radiopharmaceuticals necessitates on-site availability of a particle accelerator (cyclotron) which can transform non-radioactive atoms into radioactive atoms. At the C&RD facility, three cyclotrons are currently dedicated to producing several essential radioisotopes, which are transformed into radiopharmaceuticals, and subsequently qualified as suitable for human use through rigorous testing and quality assurance.

Research activities of the C&RD are focused on developing new radioisotopes and radioactive molecular probes with potential usefulness in molecular imaging and therapy. The facility comprises of appropriate equipment, including a micro-PET/CT for in vivo studies of the new radiotracers for achieving translational research from bench to the bed-side.

C&RD's multi-disciplinary staff is a blend of engineers, chemists, radiochemists, radiopharmacists, and quality control chemists all working toward KFSH&RC's goal of providing the specialty services in patient care. The Department is committed to the policy of Quality in Performance and Pride in Achievement.


Principle Activates

The mission of C&RD is to provide diagnostic and therapeutic radiopharmaceutical products that are manufactured by employing the highest quality standards, and to make the Kingdom of Saudi Arabia self-sufficient in all its radiopharmaceutical requirements.

 The multi-disciplinary composition of C&RD mandates all sections of the Department to have well defined goals and objectives that are collectively aimed at achieving the missions of not only the Department but also those of the Research Centre and the Hospital. These include:

  • Manufacturing diagnostic medical imaging products (radiopharmaceuticals) in compliance with the national and international standards of quality, purity, efficacy and safety.
  • Developing protocols and procedures for on time, every time supply of products to the customers.
  • Maintaining a comprehensive QMS (GMP and ISO 9001) for maximum quality and quality assurance in the radiopharmaceuticals.
  • Upgrading technologies and resources for achieving comprehensiveness in radiopharmaceuticals manufacturing.
  • Nurturing a stimulating work environment and providing opportunities to all staff for continued professional development, education, and training.
  • Developing staff with maximum number of Saudi national along with good mix of experience and expertise from abroad.
  • Engaging in collaborations with scientists within the Research Centre, KFSH&RC and external institutions in developing collaborative research projects, staff development and technology transfers.
  • Developing efficient and reliable methods for radioisotope production, and developing methods for radiolabelling biomolecules.


The unique program has produced the first radiopharmaceutical batch in 1983 has progressed steadily for over 30 years to the current capability of manufacturing several radioisotopes which are transformed into a wide range of radiopharmaceutical products. The high quality of products is substantiated from customer satisfaction and the record of diminutive untoward reaction to the patient.

Continued commitment of providing the specialty services to patients, KFSH&RC has completed the new expansion of C&RD facility to house three cyclotrons, a Tc-99m generators manufacturing facility and a “Cold Kits” manufacturing facility to provide over 95% of the all radiopharmaceutical needs in the Kingdom with surplus capacity for export to neighboring countries.



Accreditations & Awards